<?xml version="1.0" encoding="UTF-8"?>
<ref id="B66">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Islan</surname>
    <given-names>GA</given-names>
   </name>
   <name>
    <surname>Durán</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Cacicedo</surname>
    <given-names>ML</given-names>
   </name>
   <name>
    <surname>Nakazato</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Kobayashi</surname>
    <given-names>RKT</given-names>
   </name>
   <name>
    <surname>Martinez</surname>
    <given-names>DST</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Nanopharmaceuticals as a solution to neglected diseases: Is it possible?</article-title>
  <source>Acta Trop.</source> (
  <year>2017</year>) 
  <volume>170</volume>:
  <fpage>16</fpage>–
  <lpage>42</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.actatropica.2017.02.019</pub-id>
  <?supplied-pmid 28232069?>
  <pub-id pub-id-type="pmid">28232069</pub-id>
 </mixed-citation>
</ref>
